Speaker illustration

Professor Walter Paulus

AMC Medical Research BV, Amsterdam (Netherlands (The))

Dr Paulus’ main research topic is the pathophysiology of diastolic heart failure. Diastolic heart failure, also called heart failure with preserved ejection fraction, results from diastolic stiffening of the myocardium and not from reduced systolic contractile performance. In an ageing population, this form of heart failure is rapidly becoming the main heart failure phenotype observed in 60% of patients. So far, no single treatment modality has been shown to improve prognosis in diastolic heart failure. Over the last ten years, many novel pathophysiological insights relating to diastolic heart failure have been acquired in Dr Paulus’ laboratory at VU University Medical Center, Amsterdam.

HFpEF: current diagnosis and management

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session type: Symposium

Thumbnail

Drugs in heart failure - Out with the old, in with the new

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Cardiovascular Pharmacotherapy, Other

Session type: Symposium

Thumbnail

Diastology: from cellular signalling to advanced imaging techniques

Event: ESC CONGRESS 2016

Topic: Echo-ventricular function

Session type: Symposium

Thumbnail

This platform is supported by

logo Novo Nordisk